Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
192,765,632
-
Total 13F shares
-
2,415,335
-
Share change
-
-1,996,537
-
Total reported value
-
$26,155,652
-
Price per share
-
$10.83
-
Number of holders
-
23
-
Value change
-
-$19,166,471
-
Number of buys
-
19
-
Number of sells
-
20
Institutional Holders of HUMACYTE, INC. - Common Stock, par value $0.0001 per share (AHAC) as of Q1 2021
As of 31 Mar 2021,
HUMACYTE, INC. - Common Stock, par value $0.0001 per share (AHAC) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,415,335 shares.
The largest 10 holders included
Tudor Investment Corp Et Al, Alpine Global Management, LLC, Maven Securities LTD, UBS OCONNOR LLC, Eversept Partners, LP, MILLENNIUM MANAGEMENT LLC, MARSHALL WACE, LLP, BERKLEY W R CORP, Newtyn Management, LLC, and Verition Fund Management LLC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.